Ignite Creation Date:
2024-05-06 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 2:16 PM
Study NCT ID:
NCT05086692
Status:
RECRUITING
Last Update Posted:
2024-03-29
First Post:
2021-09-10
Brief Title:
A Beta-only IL-2 ImmunoTherapY Study
Sponsor:
Organization:
Medicenna Therapeutics Inc